On February 4, 2026, the Board of Directors of the Competition Authority, in exercise of the power conferred upon it by paragraph d) of No. 1 of article 19 of the Statutes, approved by Decree-Law No. 125/2014, of 18 August, resolves to adopt a decision of non-opposition regarding the notified operation, under the terms of paragraph b) of No. 1 of article 50 of the Competition Law, since it is not likely to create significant obstacles to effective competition in the national market or in a substantial part thereof.

Portuguese Competition Authority Clears Bial Portela and GSK Assets Merger

On February 4, 2026, the Board of Directors of the Portuguese competition authority, known as AdC, made a significant decision regarding the merger between Bial Portela and GSK assets.

 The authority adopted a non-opposition decision, indicating that the merger is not expected to create significant obstacles to effective competition within the national market or in a substantial part of it.

 This decision was made under the provisions of the Competition Law, specifically referencing the relevant articles that govern such concentration operations.



Portuguese Competition Authority Clears Bial Portela and GSK Assets Merger

The Portuguese competition authority has approved the merger between Bial Portela and GSK assets, determining it will not hinder competition in the market.